|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| C07C 215/44 | |||
| C07C 217/52 | |||
| C07C 219/24 | |||
| C07C 307/04 |
| (11) | Number of the document | 2546256 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12172363.9 |
| Date of filing the European patent application | 2008-08-01 | |
| (97) | Date of publication of the European application | 2013-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 963008 P | 2007-08-02 | US | |
| 62378 P | 2008-01-25 | US |
| (72) |
Armitage, Ian, US
Elliot, Eric L., US
Langston, Marianne, US
Langston, Steven, US
McCubbin, Quentin J., US
Mizutani, Hirotake, US
Stirling, Matthew, US
Zhu, Lei, US
|
| (73) |
MILLENNIUM PHARMACEUTICALS, INC.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | Process for the synthesis of E1 activating enzyme inhibitors |
| Process for the synthesis of E1 activating enzyme inhibitors |